Anogenital malignancies in women after renal transplantation over 40 years in a single center

Transplantation

Volumn 93, Issue 9, 2012, Pages 914-922

  Meeuwis, Kim A P ^a   Melchers, Willem J G ^a   Bouten, Hanneke ^b   Van De Kerkhof, Peter C M ^a   Hinten, Floor ^a   Quint, Wim G V ^c   Massuger, Leon F A G ^a   Hoitsma, Andries J ^a   Van Rossum, Michelle M ^a   De Hullu, Joanne A ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b CATHARINA HOSPITAL   (Netherlands)

^c Delft Diagnostic Laboratory   (Netherlands)

Author keywords

Anal squamous cell carcinoma; Cervical cancer; Human papillomavirus; Renal transplantation; Vulvar squamous cell carcinoma

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN A; PREDNISOLONE; THYMOCYTE ANTIBODY;

ADULT; ANOGENITAL DISEASE; ANUS CANCER; ANUS DISEASE; ARTICLE; CAUSE OF DEATH; CHILD; CHRONIC GLOMERULONEPHRITIS; CHRONIC PYELONEPHRITIS; COHORT ANALYSIS; COLON ADENOCARCINOMA; COLON CARCINOMA; CONTROLLED STUDY; CYTOLOGY; DIABETIC NEPHROPATHY; FEMALE; FEMALE GENITAL TRACT TUMOR; GENOTYPE; GYNECOLOGIC DISEASE; HISTOPATHOLOGY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFANT; KIDNEY FAILURE; KIDNEY GRAFT REJECTION; KIDNEY POLYCYSTIC DISEASE; KIDNEY TRANSPLANTATION; LIPOSARCOMA; MAJOR CLINICAL STUDY; MERKEL CELL TUMOR; MORBIDITY; MORTALITY; OVARIECTOMY; PAPILLOMAVIRUS INFECTION; PELVIS LYMPHADENECTOMY; PRESCHOOL CHILD; PRIORITY JOURNAL; RECIPIENT; RETROSPECTIVE STUDY; RISK FACTOR; SCHOOL CHILD; SQUAMOUS CELL CARCINOMA; TUMOR LOCALIZATION; UTERINE CERVIX CANCER; UTERINE CERVIX CYTOLOGY; VULVA CANCER; VULVECTOMY;

ADOLESCENT; ADULT; AGED; ANUS NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; GENITAL NEOPLASMS, FEMALE; HUMANS; INCIDENCE; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; MASS SCREENING; MIDDLE AGED; NETHERLANDS; PREVALENCE; RETROSPECTIVE STUDIES; RISK FACTORS; YOUNG ADULT;

EID: 84860730090     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e318249b13d     Document Type: Article

References (58)

1. Number of Renal Transplantations. Available at: http://www. transplantatiestichting.nl/cms/mediaobject.php?file=Jaarverslag-2009-NTS.pdf last accessed on May 28, 2011.
2. Moloney FJ, de Freitas D, Conlon PJ, et al. Renal transplantation, immunosuppression and the skin: An update. Photodermatol Photoimmunol Photomed 2005; 21: 1.
3. Howard RJ, Patton PR, Reed AI, et al. The changing causes of graft loss and death after kidney transplantation. Transplantation 2002; 73: 1923.
4. Birkeland SA, Lokkegaard H, Storm HH. Cancer risk in patients on dialysis and after renal transplantation. Lancet 2000; 355: 1886.
5. Dantal J, Hourmant M, Cantarovich D, et al. Effect of long-term immunosuppression in kidney-graft recipients on cancer incidence: Randomised comparison of two cyclosporin regimens. Lancet 1998; 351: 623.
6. Jensen P, Hansen S, Moller B, et al. Skin cancer in kidney and heart transplant recipients and different long-term immunosuppressive therapy regimens. J Am Acad Dermatol 1999; 40: 177.
7. Buell JF, Gross TG, Woodle ES. Malignancy after transplantation. Transplantation 2005; 80: S254.
8. Kasiske BL, Snyder JJ, Gilbertson DT, et al. Cancer after kidney transplantation in the United States. Am J Transplant 2004; 4: 905.
9. Vajdic CM, McDonald SP, McCredie MR, et al. Cancer incidence before and after kidney transplantation. JAMA 2006; 296: 2823.
10. Kauffman HM, Cherikh WS, McBride MA, et al. Post-transplant de novo malignancies in renal transplant recipients: The past and present. Transpl Int 2006; 19: 607.
11. Hartevelt MM, Bavinck JN, Kootte AM, et al. Incidence of skin cancer after renal transplantation in The Netherlands. Transplantation 1990; 49: 506.
12. Penn I. Posttransplantation de novo tumors in liver allograft recipients. Liver Transpl Surg 1996; 2: 52.
13. Penn I. Cancers in renal transplant recipients. Adv Ren Replace Ther 2000; 7: 147.
14. Alloub MI, Barr BB, McLaren KM, et al. Human papillomavirus infection and cervical intraepithelial neoplasia in women with renal allografts. BMJ 1989; 298: 153.
15. Busnach G, Civati G, Brando B, et al. Viral and neoplastic changes of the lower genital tract in women with renal allografts. Transplant Proc 1993; 25: 1389.
16. Fairley CK, Sheil AG, McNeil JJ, et al. The risk of ano-genital malignancies in dialysis and transplant patients. Clin Nephrol 1994; 41: 101.
17. Halpert R, Fruchter RG, Sedlis A, et al. Human papillomavirus and lower genital neoplasia in renal transplant patients. Obstet Gynecol 1986; 68: 251.
18. Meeuwis KA, van Rossum MM, van de Kerkhof PC, et al. Skin cancer and (pre)malignancies of the female genital tract in renal transplant recipients. Transpl Int 2010; 23: 191.
19. Ozsaran AA, Ates T, Dikmen Y, et al. Evaluation of the risk of cervical intraepithelial neoplasia and human papilloma virus infection in renal transplant patients receiving immunosuppressive therapy. Eur J Gynaecol Oncol 1999; 20: 127.
20. Paternoster DM, Cester M, Resente C, et al. Human papilloma virus infection and cervical intraepithelial neoplasia in transplanted patients. Transplant Proc 2008; 40: 1877.
21. Penn I. Cancers of the anogenital region in renal transplant recipients. Analysis of 65 cases. Cancer 1986; 58: 611.
22. Schneider V, Kay S, Lee HM. Immunosuppression as a high-risk factor in the development of condyloma acuminatum and squamous neoplasia of the cervix. Acta Cytol 1983; 27: 220.
23. Porreco R, Penn I, Droegemueller W, et al. Gynecologic malignancies in immunosuppressed organ homograft recipients. Obstet Gynecol 1975; 45: 359.
24. Sunesen KG, Norgaard M, Thorlacius-Ussing O, et al. Immunosuppressive disorders and risk of anal squamous cell carcinoma: A nationwide cohort study in Denmark, 1978Y2005. Int J Cancer 2010; 127: 675.
25. European best practice guidelines for renal transplantation. Section IV: Long-term management of the transplant recipient. IV. 6.3. Cancer risk after renal transplantation. Solid organ cancers: Prevention and treatment. Nephrol Dial Transplant 2002; 17(suppl 4): 32, 34Y32, 36.
26. KDIGO clinical practice guideline for the care of kidney transplant recipients. Am J Transplant 2009; 9(suppl 3): S1.
27. Brown MR, Noffsinger A, First MR, et al. HPV subtype analysis in lower genital tract neoplasms of female renal transplant recipients. Gynecol Oncol 2000; 79: 220.
28. Kasiske BL, Vazquez MA, Harmon WE, et al. Recommendations for the outpatient surveillance of renal transplant recipients. American Society of Transplantation. J Am Soc Nephrol 2000; 11(suppl 15):S1.
29. Gentile G, Formelli G, Orsoni G, et al. Immunosuppression and human genital papillomavirus infection. Eur J Gynaecol Oncol 1991; 12: 79.
30. Veroux M, Corona D, Scalia G, et al. Surveillance of human papilloma virus infection and cervical cancer in kidney transplant recipients: Preliminary data. Transplant Proc 2009; 41: 1191.
31. Bekkers RL, Massuger LF, Bulten J, et al. Epidemiological and clinical aspects of human papillomavirus detection in the prevention of cervical cancer. Rev Med Virol 2004; 14: 95.
32. van de Nieuwenhof HP, van der Avoort I, de Hullu JA. Review of squamous premalignant vulvar lesions. Crit Rev Oncol Hematol 2008; 68: 131.
33. van der Avoort I, Shirango H, Hoevenaars BM, et al. Vulvar squamous cell carcinoma is a multifactorial disease following two separate and independent pathways. Int J Gynecol Pathol 2006; 25: 22.
34. Parkin DM, Bray F. Chapter 2: The burden of HPV-related cancers. Vaccine 2006; 24(suppl 3): S3/11.
35. Joseph DA, Miller JW, Wu X, et al. Understanding the burden of human papillomavirus-associated anal cancers in the US. Cancer 2008; 113: 2892.
36. Tachezy R, Jirasek T, Salakova M, et al. Human papillomavirus infection and tumours of the anal canal: Correlation of histology, PCR detection in paraffin sections and serology. APMIS 2007; 115: 195.
37. Uronis HE, Bendell JC. Anal cancer: An overview. Oncologist 2007; 12: 524.
38. Daling JR, Madeleine MM, Johnson LG, et al. Human papillomavirus, smoking, and sexual practices in the etiology of anal cancer. Cancer 2004; 101: 270.
39. Frisch M, Glimelius B, van den Brule AJ, et al. Sexually transmitted infection as a cause of anal cancer. N Engl J Med 1997; 337: 1350.
40. Hoots BE, Palefsky JM, Pimenta JM, et al. Human papillomavirus type distribution in anal cancer and anal intraepithelial lesions. Int J Cancer 2009; 124: 2375.
41. van Seters M, van Beurden M, de Craen AJ. Is the assumed natural history of vulvar intraepithelial neoplasia III based on enough evidence? A systematic review of 3322 published patients. Gynecol Oncol 2005; 97: 645.
42. de Bie RP, van de Nieuwenhof HP, Bekkers RL, et al. Patients with usual vulvar intraepithelial neoplasia-related vulvar cancer have an increased risk of cervical abnormalities. Br J Cancer 2009; 101: 27.
43. van de Nieuwenhof HP, Massuger LF, van der Avoort I, et al. Vulvar squamous cell carcinoma development after diagnosis of VIN increases with age. Eur J Cancer 2009; 45: 851.
44. van de Nieuwenhof HP, van Kempen LC, de Hullu JA, et al. The etiologic role of HPV in vulvar squamous cell carcinoma fine tuned. Cancer Epidemiol Biomarkers Prev 2009; 18: 2061.
45. Darragh TM, Winkler B. Anal cancer and cervical cancer screening: Key differences. Cancer Cytopathol 2011; 119: 5.
46. Scholefield JH, Castle MT, Watson NF. Malignant transformation of high-grade anal intraepithelial neoplasia. Br J Surg 2005; 92: 1133.
47. Wong G, Howard K, Webster A, et al. The health and economic impact of cervical cancer screening and human papillomavirus vaccination in kidney transplant recipients. Transplantation 2009; 87: 1078.
48. Trottier H, Ferreira S, Thomann P, et al. Human papillomavirus infection and reinfection in adult women: The role of sexual activity and natural immunity. Cancer Res 2010; 70: 8569.
49. Theiler RN, Farr SL, Karon JM, et al. High-risk human papillomavirus reactivation in human immunodeficiency virus-infected women: Risk factors for cervical viral shedding. Obstet Gynecol 2010; 115: 1150.
50. Bosch FX, Lorincz A, Munoz N, et al. The causal relation between human papillomavirus and cervical cancer. J Clin Pathol 2002; 55: 244.
51. Meeuwis KA, van Rossum MM, Hoitsma AJ, et al. (Pre)malignancies of the female anogenital tract in renal transplant recipients. Transplantation 2011; 91: 8.
52. Ogunbiyi OA, Scholefield JH, Raftery AT, et al. Prevalence of anal human papillomavirus infection and intraepithelial neoplasia in renal allograft recipients. Br J Surg 1994; 81: 365.
53. Hampl M, Wentzensen N, Vinokurova S, et al. Comprehensive analysis of 130 multicentric intraepithelial female lower genital tract lesions by HPV typing and p16 expression profile. J Cancer Res Clin Oncol 2007; 133: 235.
54. de Sanjose S, Quint WG, Alemany L, et al. Human papillomavirus genotype attribution in invasive cervical cancer: A retrospective crosssectional worldwide study. Lancet Oncol 2010; 11: 1048.
55. Edey M, Barraclough K, Johnson DW. Review article: Hepatitis B and dialysis. Nephrology (Carlton) 2010; 15: 137.
56. Casparie M, Tiebosch AT, Burger G, et al. Pathology databanking and biobanking in The Netherlands, a central role for PALGA, the nationwide histopathology and cytopathology data network and archive. Cell Oncol 2007; 29: 19.
57. Melchers WJ, Bakkers JM, Wang J, et al. Short fragment polymerase chain reaction reverse hybridization line probe assay to detect and genotype a broad spectrum of human papillomavirus types. Clinical evaluation and follow-up. Am J Pathol 1999; 155: 1473.
58. Snijders PJ, Hogewoning CJ, Hesselink AT, et al. Determination of viral load thresholds in cervical scrapings to rule out CIN 3 in HPV 16, 18, 31 and 33-positive women with normal cytology. Int J Cancer 2006; 119: 1102.